Supernus Pharmaceuticals recalls
FDA enforcement reports naming Supernus Pharmaceuticals, Inc. as the recalling firm.
- Recall reports
- 3
- Class I (serious)
- 0
- Most recent report
- Sep 9, 2026
- Sep 9, 2026Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manuf…Drug · Supernus Pharmaceuticals, Inc.Failed dissolution specifications.Class III
- Jul 29, 2026Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufact…Drug · Supernus Pharmaceuticals, Inc.Failed Dissolution SpecificationsClass III
- Oct 26, 2016Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only…Drug · Supernus Pharmaceuticals, Inc.Superpotent Drug: Failure of assay specifications in the capsule.Class II